Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is Continuous Treatment with Transforming Growth Factor-Beta Necessary to Induce Chondrogenic Differentiation in Mesenchymal Stem Cells?

29 Aug 2008

Abstract excerpt

This study was conducted to determine whether short-term administration of transforming growth factor (TGF)-beta would be as effective for inducing chondrogenesis in human mesenchymal stem cells (hMSCs) as continuous treatment. Four groups of hMSCs were cultured in a monolayer for 3 days followed by a pellet culture for 3 weeks under various conditions: group A, the control group, no growth factors treated; group...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mesenchymal stem cell research
Share to Osteoarthritis Treatment and Mechanisms
Share to Periodontal Regeneration and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18756084
DOI: 10.1159/000153041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is Continuous Treatment with Transforming Growth Factor-Beta Necessary to Induce Chondrogenic Differentiation in Mesenchymal Stem Cells?PMID 18756084Read ↗

Chondrocytes or adult stem cells for cartilage repair: the indisputable role of growth factors.Semantic proximity Read ↗

Growth factor-defined culture medium for human mesenchymal stem cellsSemantic proximity Read ↗

Adenoviral-mediated transfer of TGF-β1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet culturesSemantic proximity Read ↗

Growth Factor Gene-Modified Mesenchymal Stem Cells in Tissue RegenerationSemantic proximity Read ↗

Wnt inhibitors enhance chondrogenesis of human mesenchymal stem cells in a long-term pellet cultureSemantic proximity Read ↗

In vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells in monolayer culture: activation by transfection with TGF-β2Semantic proximity Read ↗

FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-β signalingSemantic proximity Read ↗

Determination of the Chondrogenic Differentiation Processes in Human Bone Marrow-Derived Mesenchymal Stem Cells Genetically Modified to Overexpress Transforming Growth Factor-β via Recombinant Adeno-Associated Viral VectorsSemantic proximity Read ↗

Co-overexpression of TGF-β and SOX9 via rAAV gene transfer modulates the metabolic and chondrogenic activities of human bone marrow-derived mesenchymal stem cellsSemantic proximity Read ↗

Hypoxia Preconditioned Serum (HPS) Promotes Proliferation and Chondrogenic Phenotype of Chondrocytes In Vitro.Semantic proximity Read ↗

A chondromimetic microsphere for in situ spatially controlled chondrogenic differentiation of human mesenchymal stem cells.Semantic proximity Read ↗

Enhanced chondrogenesis of bone marrow-derived stem cells by using a combinatory cell therapy strategy with BMP-2/TGF-β1, hypoxia, and COL1A1/HtrA1 siRNAsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.